---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-036651"
form_type: "8-K"
ticker: "NUWE"
cik: "0001506492"
company_name: "Nuwellis, Inc."
filed_at: "2025-09-30T23:59:59+00:00"
generated_at: "2026-05-17T05:15:15.073683+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Nuwellis announces ULTRA-Peds registry study findings on Aquadex System in pediatric AKI

## Summary
- ULTRA-Peds registry is multi-center observational study of real-world Aquadex System use.
- Study focused on children with acute kidney injury, fluid overload, or congenital kidney failure.
- Findings announced September 30, 2025; no quantitative results or patient numbers disclosed.
- Company did not provide financial impact or guidance change in this filing.

## SEC filing metadata
- accession: 0001140361-25-036651
- form_type: 8-K
- ticker: NUWE
- cik: 0001506492
- company_name: Nuwellis, Inc.
- filed_at: 2025-09-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506492/000114036125036651/0001140361-25-036651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506492/000114036125036651/ef20056233_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-036651
- JSON: https://secwatch.observer/filing/0001140361-25-036651.json
- Plain text: https://secwatch.observer/filing/0001140361-25-036651.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.